Skip to Content
Merck
CN

09779

Fmoc-12-Ado-OH

≥98.0% (TLC)

Synonym(s):

12-(Fmoc-amino)dodecanoic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C27H35NO4
CAS Number:
128917-74-8
Molecular Weight:
437.57
UNSPSC Code:
12352209
NACRES:
NA.26
PubChem Substance ID:
329748826
MDL number:
MFCD00235888
Beilstein/REAXYS Number:
9593537

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI

1S/C27H35NO4/c29-26(30)18-8-6-4-2-1-3-5-7-13-19-28-27(31)32-20-25-23-16-11-9-14-21(23)22-15-10-12-17-24(22)25/h9-12,14-17,25H,1-8,13,18-20H2,(H,28,31)(H,29,30)

SMILES string

OC(=O)CCCCCCCCCCCNC(=O)OCC1c2ccccc2-c3ccccc13

InChI key

HVGIKYAQSSNFCH-UHFFFAOYSA-N

assay

≥98.0% (TLC)

form

powder

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

color

white

mp

114-118 °C

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-8°C

Quality Level

100

Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCB7406

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jing Han et al.
Molecular pharmaceutics, 15(7), 2840-2856 (2018-05-26)
GLP-1 analogs suffer from the main disadvantage of a short in vivo half-life. Lithocholic acid (LCA), one of the four main bile acids in the human body, possesses a high albumin binding rate. We therefore envisioned that a LCA-based peptide
Christos Kontos et al.
Nature communications, 11(1), 5981-5981 (2020-11-27)
Targeting a specific chemokine/receptor axis in atherosclerosis remains challenging. Soluble receptor-based strategies are not established for chemokine receptors due to their discontinuous architecture. Macrophage migration-inhibitory factor (MIF) is an atypical chemokine that promotes atherosclerosis through CXC-motif chemokine receptor-4 (CXCR4). However

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service